In particular, hedge fund managers, using their vast resources and analytical capabilities, are more receptive to such ...

Analysts are piling on the praise for Vertex Pharmaceuticals, reaffirming bullish ratings even as the stock slightly fumbles ...

As scientific interest in psychedelic-assisted therapies continues to surge, MindScape Retreat, a licensed Ibogaine treatment center located on the peaceful island of Cozumel, Mexico, is establishing ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Decentralized Biotechnology Intelligence Holding Group Inc. (dBio), a leading innovator in sports and health tech, delivering ...

Wilson Community College is building a biotechnology and workforce center to prepare students for jobs in the biotech ...

While much of the conversation around the Trump administration’s potential pharmaceutical import tariffs has leaned heavily ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has surged by 7.02%, which has investors questioning if this is right time to sell.

It’s been a volatile few years for Neuren, the neurological disorder treatment group which has seen shares rocket, then slump ...

Smith, Head of Business Development, Douglas CDMO, touts the advantages of and dispels misconceptions about mid-sized CDMOs.

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

Synthetic Design Lab, a next-generation antibody-drug conjugate (ADC) company advancing its novel SYNTHBODY therapeutic platform against a range of cancer indications, emerged from stealth today with ...